Global Hemorrhoid Treatment Market Size Share Trends and Forecast 2034
Global Hemorrhoid Treatment Market Size Share Trends and Forecast 2034
The Hemorrhoid treatment market growth in 2026 includes a wide range of options such as topical medications, oral drugs, minimally invasive procedures, and surgical interventions. The rising preference for over-the-counter (OTC) products, coupled with technological advancements in treatment procedures, is significantly contributing to the market growth. Additionally, increasing healthcare expenditure and improved access to medical services are further supporting the adoption of hemorrhoid treatment solutions globally.
According to Fortune Business Insights, the global hemorrhoid treatment market size was valued at USD 1.14 billion in 2025. The market is projected to grow from USD 1.20 billion in 2026 to USD 2.00 billion by 2034, exhibiting a CAGR of 6.59% during the forecast period. The increasing prevalence of gastrointestinal disorders, rising awareness regarding anorectal health, and growing demand for minimally invasive treatment options are key factors supporting the expansion of this market. Hemorrhoids, commonly known as piles, are swollen veins in the lower rectum and anus that can cause discomfort, pain, and bleeding, thereby driving the demand for effective therapeutic solutions.
Lupin (India)
Cipla (India)
AMATO PHARMACEUTICAL PRODUCTS, LTD. (Japan)
Church & Dwight Co., Inc. (U.S.)
Haleon Group of Companies (U.K.)
Sebela Pharmaceuticals (U.S.)
Bayer AG (Germany)
Sanofi (France)
Abbott (U.S.)
Sun Pharmaceutical Industries, Inc. (India)
The growing incidence of hemorrhoids due to sedentary lifestyles, poor dietary habits, and rising obesity rates is a major driver for the hemorrhoid treatment market. Increasing consumption of low-fiber diets and reduced physical activity contribute to constipation, which is one of the primary causes of hemorrhoids. Furthermore, the aging population is more susceptible to anorectal disorders, thereby boosting demand for treatment solutions.
The availability of a wide range of OTC medications such as creams, ointments, and suppositories has enhanced accessibility to treatment, supporting market expansion. In addition, the increasing adoption of minimally invasive procedures such as rubber band ligation and sclerotherapy is improving patient outcomes and reducing recovery time.
However, the market faces certain restraints, including the stigma associated with discussing anorectal conditions, which may lead to underdiagnosis and delayed treatment. Additionally, side effects associated with certain medications and the high cost of advanced surgical procedures may limit market growth to some extent.
The report provides a comprehensive analysis of the hemorrhoid treatment market, focusing on key aspects such as market size, growth trends, and competitive dynamics. It offers detailed insights into various treatment types, including medications and procedures, along with an evaluation of technological advancements shaping the market. The report also highlights key industry developments, regulatory frameworks, and strategic initiatives adopted by major players to strengthen their market presence.
In addition, the report includes an in-depth analysis of market drivers, restraints, opportunities, and challenges. It also examines evolving consumer preferences and the impact of lifestyle changes on the demand for hemorrhoid treatment products. The inclusion of data-driven insights and forecasts helps stakeholders make informed business decisions.
The hemorrhoid treatment market is characterized by the presence of several established pharmaceutical companies and healthcare providers. Key players are focusing on product innovation, strategic collaborations, and mergers and acquisitions to enhance their market position. The introduction of advanced formulations and minimally invasive treatment options is enabling companies to cater to the growing demand for effective and convenient solutions.
Companies are also investing in research and development activities to develop new therapies with improved efficacy and fewer side effects. The increasing emphasis on expanding distribution networks and strengthening online sales channels is further contributing to competitive growth in the market.
The hemorrhoid treatment market is segmented based on treatment
By Product Type (Suppository, Sprays, Creams & Ointments, and Others)
By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Local Anesthetics, Corticosteroids, and Others)
By Type (Internal {Grade I, Grade II, Grade III, and Grade IV}, and External)
By Distribution Channel (Hospital Pharmacy, Drug Stores & Retail Pharmacy, and Online Pharmacy)
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/hemorrhoid-treatment-market-110985
North America dominated the hemorrhoid treatment market with a market share of 44.29% in 2025. The dominance of this region is attributed to the high prevalence of hemorrhoids, advanced healthcare infrastructure, and strong presence of leading market players. Additionally, increasing awareness about available treatment options and higher healthcare spending are supporting market growth.
Other regions are also witnessing steady growth due to improving healthcare facilities, rising awareness, and increasing adoption of advanced treatment methods. The growing focus on early diagnosis and treatment is expected to further drive market expansion globally.
The future of the hemorrhoid treatment market looks promising, with significant growth opportunities driven by technological advancements and increasing awareness about anorectal health. The development of innovative treatment solutions, including non-invasive and minimally invasive procedures, is expected to enhance patient outcomes and drive market growth.
Furthermore, the rising adoption of digital healthcare platforms and telemedicine services is expected to improve access to treatment and consultation. The increasing focus on preventive healthcare and lifestyle modifications is also anticipated to reduce the incidence of hemorrhoids while supporting the demand for early-stage treatments.
As healthcare systems continue to evolve, market players are expected to focus on expanding their product portfolios and strengthening their global presence. Strategic partnerships and investments in research and development will play a crucial role in shaping the future of the hemorrhoid treatment market.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com